PharmaResearch Co., Ltd.
Research PharmaResearch Co., Ltd. (214450.KQ) on Bullrun: market cap KRW 2.89T, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker214450.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CurrencyKRW
- Market capKRW 2.89T
- Dividend yield1.3%
- Financial periodQ2 2026
- RevenueKRW 178.70B
- Net incomeKRW 56.57B
- Free cash flowKRW 19.97B
- Gross margin77.0%
Valuation Snapshot
latest market cap is KRW 2.89T; dividend yield is 1.3%.
Peer valuation comparison
Latest dividend yield is 1.33% versus a Healthcare sector median of 2.4% (44.6% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 2.89T | n/a | 1.3% | 3700 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3700 KRW, yield 1.3%.
About PharmaResearch Co., Ltd.
PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is PharmaResearch Co., Ltd.'s market cap?
PharmaResearch Co., Ltd.'s market capitalization is KRW 2.89T.
Does PharmaResearch Co., Ltd. pay a dividend?
PharmaResearch Co., Ltd. has a dividend yield of 1.3%.
What does PharmaResearch Co., Ltd. do?
PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea.